Upload
dinhthuy
View
219
Download
4
Embed Size (px)
Citation preview
CURRICULUM VITAE
JOEL WERIER
Joel Werier
Printed 2015 October 27 2
Updated 2015 Aug 1
SUMMARY
Name Joel Werier
Born 1967 Apr 13
Languages English: spoken and written
Office Address Ottawa Hospital General Campus
501 Smyth Road, Suite 1661
Ottawa, Ontario, Canada
K1H 8L6
Telephone 613-737-8213
Fax 613-737-8150
Email [email protected]
Home Address 73 Irving Place
Ottawa, Ontario, Canada
K1Y 2A2
Telephone 613-761-7948
Email [email protected]
Current Positions Cancer Care Ontario Sarcoma Services Steering Committee, Cancer Care Ontario,
Ontario, Canada, 2011 Jan - present
Royal College of Physician and Surgeons of Canada examiner orthopaedic surgey,
exam development oncology, Royal College of Physician and Surgeons of Canada,
2010 Jan - present
Cancer Care Ontario Sarcoma Disease Site Group
Program in Evidence Based Care, Cancer Care Ontario Sarcoma Disease Site Group,
Ontario, Canada, 2009 Nov - present
Program Director - Division of Orthopaedic Surgery - University of Ottawa,
University of Ottawa, Ottawa, Ontario, Canada, 2008 Jun - present
Secretary, Canadian Orthopaedic Oncology Society, 2008 Jul - present
Lead - Sarcoma Site Group/The Ottawa Hospital Sarcoma Program, Ottawa Hospital
Cancer Program, 2003 Jan - present
Consultant Orthopaedic Oncologist Children’s Hospital of Eastern Ontario,
Children’s Hospital of Eastern Onterio, 2003 Jan - present
Clinical Investigator, Ottawa Hospital Research Institute, 2003 Jan - present
Current Appointments Active, The Ottawa Hospital, Department of TOH Surgery, Division of Orthopedic
Surgery
Joel Werier
Printed 2015 October 27 3
Assistant Professor, University of Ottawa, Department of Surgery, Division of
Orthopedic Surgery
EDUCATION AND QUALIFICATIONS
Degrees and Diplomas
2000 - 2002 fellowship, Orthopaedic Oncology, Musculoskeletal Oncology Unit, Mount Sinai Hospital,
University of Toronto, Toronto, Ontario, Canada, Supervisor: Dr. Robert Bell
1999 - 2000 fellowship, Hand and Microvascular Surgery, Christine M. Kleinert Institute for Hand,
University of Louisville, Louisville, Kentucky, United States, Supervisor: Dr. Harold Kleinert
1998 - 1999 fellowship, Hand and Upper Limb, Hand and Upper Limb Centre, St. Joseph’s Hospital,
University of Western Ontario, London, Ontario, Canada
1993 - 1998 FRCSC, Orthopaedic Surgery, Orthopaedic Surgery Residency Program, University of British
Columbia, Vancouver, British Columbia, Canada
1991 - 1992 Rotating Internship, Rotating Internship, Ottawa Civic Hospital, Ottawa, Ontario, Canada
1987 - 1991 MD, University of Manitoba, Canada
1987 - 1991 BSc, University of Manitoba, Canada
1985 - 1987 Faculty of Science, University of Winnipeg
Qualifications, Licensures and Certifications
2005 Diplomate American Board of Orthopaedic Surgery
1998 Royal College of Physcians and Surgeons Canada
1993 College Physicians and Surgeons British Columbia
1992 College of Physicians and Surgeons Ontario
Research Training
2001 - 2002 Wound at risk animal model, Pathology, Mount Sinai Hospital, Toronto, Supervisor: Dr. Rita
Kandel
Joel Werier
Printed 2015 October 27 4
EDUCATION AND CAREER EXPERIENCE
Honours and Awards
2009 - 2010 Dr. Jacques Robichon Award for Exemplary Service, University of Ottawa Division of
Orthopaedic Surgery, Awarded by the Division of Orthopaedic Surgery for Exemplary
Service, Ottawa, Ontario, Canada
2007 Recipient Guardian Angel Award, The Ottawa Hospital
Teaching Awards
2006 - 2007 Orthopaedic Staff Teaching Award, division of orthopaedic surgery
2006 honorable mention for award for excellence and innovation in post graduate medical
education, University of Ottawa
Positions Held
2011 - 2014 Vice Chair Orthopaedic Surgery Specialty Committee, Royal College of Physicians and
Surgeons of Canada, Canada
2005 - 2011 Co-Primary Investigator, The Ottawa Hospital Tumour Banking Program, Ottawa, Ontario,
Canada
2006 - 2009 President, National Capital Orthopaedic Association
1992 - 1993 Emergency Physician, Grace General Hospital
University Appointments
Assistant Professor, Division of Orthopedic Surgery, Department of Surgery, University of
Ottawa
Hospital Appointments
2004 Active, Division of Orthopedic Surgery, Department of TOH Surgery, The Ottawa Hospital
Joel Werier
Printed 2015 October 27 5
RESEARCH AND SCHOLARLY ACTIVITIES
Research Endeavours
2015 - present A MULTICENTER RANDOMIZED, OPEN-LABEL PHASE II/III STUDY, TO COMPARE
THE EFFICACY OF NBTXR3, IMPLANTED AS INTRATUMOR INJECTION AND
ACTIVATED BY RADIOTHERAPY, VERSUS RADIOTHERAPY ALONE IN PATIENTS
WITH LOCALLY ADVANCED SOFT TISSUE SARCOMA OF THE EXTREM, Local
Co-PI rA MULTICENTER RANDOMIZED, OPEN-LABEL PHASE II/III STUDY, TO
COMPARE THE EFFICACY OF NBTXR3, IMPLANTED AS INTRATUMOR
INJECTION AND ACTIVATED BY RADIOTHERAPY, VERSUS RADIOTHERAPY
ALONE IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMA OF
THE EXTREMITY AND TRUNK WALL
2015 - present Standardization of a self-report measure of physical function in paediatric bone tumour
patients, CHEO REB #14/86x - standardiation and validation of pediatric version (pTESS)
of Toronto Extremity Salvage Score. Collaboration with Hospital for Sick Children, Toronto
2014 - present 11-6 Optimal strategies of Ewing’s sarcoma - Program of Evidence Based Care Cancer Care
Ontario, lead 11-6 PEBC guidline
2014 - 2015 Giant Cell Tumour of Bone Protocol 2011534-01H, multicentre data base review for Giant
Cell Tumour Bone
2014 - 2015 Treatment and Oncologic Outcomes of Soft Tissue Osteosarcoma Protocol 20140354,
multicentre dataset review of soft tissue osteosarcoma
2013 - present Ottawa Bone Oncology Program ( OBOP ), Collaborative Prorgam (Addison, Clemons
(OHRI)) - A feasibility study of Tissue Collection from Patients undergoing orthopaedic
surgery with metastatic bone disease
2013 - present Prophylactic Antibiotic Regimens in Tumour Surgery ( PARITY) protocol 20120375-0H1,
Multicentre randomized Controlled Trial Comparing Alternative Antibiotic Regimens in
Patients Undergoing Tumor Resection with Endoprosthetic Replacements. Partner Centre
2013 - present Smoking Cessation in the Fracture Clinic protocol 20130239-01H, The overall objective of
this study is to assess the effectiveness of introducing The Ottawa Model for Smoking
Cessation to the current standard of care within the setting of The Ottawa Hospital’s Fracture
Clinic at the Civic Campus. The Ottawa Model has been successfully implemented within
multiple inpatient and outpatient settings at The Ottawa Hospital in addition to 144 settings
across Canada. The primary objective of the study will be to compare 12-month cessation
rates pre- and post-implementation of the Ottawa Model. Secondary objectives include
evaluation of effects on short-term (3- and 6-month) cessation rates, SF36v2 Functional
Health Questionnaire scores, and rates of orthopaedic complications, defined as non unions,
delayed unions, infection, and revision surgical interventions.
2013 - present The use of Vacuum assisted closure in sarcoma surgery. Wounds at risk, patient accrual in
progress, Comparing would breakdown rates with radiation and sarcoma surgery with use of
incisional VAC technique compared to SR-2 trial ( O’Sullivan, Lancet, 2002)
Joel Werier
Printed 2015 October 27 6
2013 - 2014 Companion-to-Man Biotherapies Group (C-Big): Veterinary Trial for the evaluation of
Oncollytic Maraba Virus in Canaine Osteosarcoma, Collaboration with JS Diallo ( OHRI),
Hesham Abdelbary (OHRI), Dean Fergusson (OHRI) and Gulph Veterinary College (Bridle,
Lichty, Wood, Mutsaers) developing protcol for Oncolytic viral treatment in spontaneous
canine osteosarcoma model. CIHR competition Sept 16, 2013 application 313293 not
funded.
2011 - 2014 Intensive Orthopaedic Orientation, Novel educational initiative to compare retention rates of
critical orthopaedic knowledge after intevsive course
2010 - 2015 protocol 2010733-01H Interpreting MSK Tumors, what effect does specialty experience
have? collaboration between Werier, Schweitzer, El Maadawy
2010 - 2014 Multi-institutional quantitative MRI perfusion imaging of musculoskeletal neoplasms,
collaboration Werier, Schweitzer Cron. CIHR grant application 222333 (Unfunded)
2010 - 2013 CT Perfusion; a biomarker of the biological aggressiveness and treatment response of
muscloskeletal tumors, collaboration Werier, Schweitzer, Cron.
2010 - 2013 Protocol #2010731-01H - Additive Values of CT Scan to MRI in Interpretation of
Musculoskeletal Tumours, collaboration between Werier, Schweitzer, El Maadawy
2008 - 2012 Genomic Medicine: Translating Disease Gene Discovery to Clinical Care, Collaboration with
Kandel Lab Toronto. (collection blood and tumour samples)
2004 - present Interdisciplinary Health Rersearch Team in Muscoloskeletal Neoplasia Protocol
2003109-OH1, sarcoma tumour banking and prospective database with Toronto and Montreal
2004 - present viral oncolytic therapy and musculoskeltal oncology, ongoing collaborative program with the
lab of Dr. John Bell, JS Diallo
Grants
2013 - 2015 Smoking Cessation within the Fracture Clinic, The Ottawa Hospital Academic Medical
Organization(TOHAMO) and Innovation Fund Provincial Oversight Committee, $50,000,
Principal or Joint Investigator, PI: J. Werier
2013 - 2015 Smoking Cessation within the Fracture Clinic, Department of Surgery, University of Ottawa,
$25,000, Principal or Joint Investigator, PI: J. Werier
2012 - present Novel Therapeutics in Sarcoma Initiative, Valerie’s Flutter Foundation, $52,750, Principal or
Joint Investigator, PI: Joel Werier
2012 - 2013 Intensive Orthopaedic Orientation Course, Faculty of Medicine - University of Ottawa,
$8,500, Principal or Joint Investigator, PI: Joel Werier
2009 - 2010 Prospective Randomized Controlled Study comparing the FIXION expandable nail versus
plate and screw fixation for Pathahlogic humeral fractures, Ottawa Regional Cancer
Foundation, $18,000, Principal or Joint Investigator, PI: Werier, J
2004 - 2006 Interdisciplinary Health Research Team in Musculoskeltal Neoplasia - Canadian Sarcoma
Group, NCIC, Collaborator, PI: Dr. Robert Bell
Joel Werier
Printed 2015 October 27 7
2004 - 2006 The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
Clinically-Important Venous Thromboembolism Following Lower Extremity Fractures:
Epidemiology & Prevention, Principal or Joint Investigator
Supervision
2015 Dr. Kevin Rasuli, Senior Resident - Teaching
2015 Dr. Aaron Frombach, Senior Resident - Teaching
2015 Dr. Nada Gawad, Senior Resident - Teaching
2015 Dr. Michael D’Elia, Senior Resident - Teaching
2015 Dr. Caleb Netting, Senior Resident - Teaching
2015 Dr. Niket Gandi, Senior Resident - Teaching
2015 Dr. Mathew Lipinski, Senior Resident - Teaching
2015 Dr. Shannon Fernando, Senior Resident - Teaching
2014 - 2015 Dr. Mitch Armstrong, Senior Resident - Teaching
2014 - 2015 Dr. Brittany Ellis, Senior Resident - Teaching
2014 - 2015 Dr. Shawn Verma, Senior Resident - Teaching
2014 - 2015 Dr. Alexandre Tomic, Fellow - Teaching
2014 Dr. Ian MacNiven, Senior Resident - Teaching
2014 Dr. Andrew Stewart, Senior Resident - Teaching
2014 Dr. Brian Le, Senior Resident - Teaching
2014 Dr. Bogdan Matache, Senior Resident - Teaching
2014 Dr. Isabella Miles, Senior Resident - Teaching
2014 Dr. Andrew Bodrogi, Senior Resident - Teaching
2014 Dr. Jeff Landreville, Senior Resident - Teaching
2014 Dr.Ariel Hendin, Senior Resident - Teaching
2014 Dr.Miguel Cortel, Senior Resident - Teaching
2014 Dr. John Morellato, Senior Resident - Teaching
2014 Dr. Andrew Tice, Senior Resident - Teaching
2013 - 2015 Dr. Dr. Sadegh Saberi, Fellow - Teaching
Joel Werier
Printed 2015 October 27 8
2013 - 2014 Dr. Kristi Wood, Senior Resident - Teaching
2013 - 2014 Dr. Julie Kim, Senior Resident - Teaching
2013 Dr. Thara Kumar, Senior Resident - Teaching
2013 Dr. Simeon Mitchell, Senior Resident - Teaching
2013 Dr. Andrew Tice, Senior Resident - Teaching
2013 Dr. Heathcliff D’Sa, Senior Resident - Teaching
2013 Dr. Christopher Dowding, Senior Resident - Teaching
2013 Dr. Gillian Bayley, Senior Resident - Teaching
2013 Dr. Scott McGuffin, Senior Resident - Teaching
2013 Dr. Christopher Dowding, 3 block research rotation
2013 Dr. Heathcliff D’Sa, 3 block research rotation
2012 - 2013 Dr. Travis Marion, Senior Resident - Teaching
2012 - 2013 Dr. Krista Goulding, Fellow - Teaching
2012 De. Theresa Pazionis, External Elective Rotation - Teaching
2012 Dr. Bradley Meulenkamp, 1 block research rotation
2012 Dr. Marie-France Rancourt, 3 block research rotation
2012 Dr. Kelly Hynes, Senior Resident - Teaching
2012 Dr. Ian MacNiven, Senior Resident - Teaching
2012 Dr. Mathew MacEwan, Senior Resident - Teaching
2012 Dr. Travis Marion, 2 block research rotation
2012 Dr. Sean Smith, Senior Resident - Teaching
2012 Dr. Cai Wadden, Senior Resident - Teaching
2012 Dr. Natasha Holder, Senior Resident - Teaching
2011 - 2015 Dr. Markian Pahuta, Ph.D. - Research
2011 - 2012 Dr. Geoff Wilkin, Senior Resident - Teaching
2011 - 2012 Dr. Sabig Edrees, Fellow - Teaching
2011 Dr. Marc Prud’homme Foster, Senior Resident - Teaching
Joel Werier
Printed 2015 October 27 9
2011 Dr. Mark Pahuta, Senior Resident - Teaching
2011 Dr. Nathan Sacevich, Senior Resident - Teaching
2011 Dr. Marie-France Rancourt, Senior Resident - Teaching
2011 Dr. Sasha Carsen, Senior Resident - Teaching
2011 Dr. Bradley Meulenkamp, 2 block research rotation
2011 Dr. Bradley Meulenkamp, Senior Resident - Teaching
2010 - 2011 Dr. Derek Butterwick, 3 block research rotation
2010 - 2011 Dr. Hesham Abdelbary, Fellow - Teaching
2010 - 2011 Dr. William Desloges, Senior Resident - Teaching
2010 Dr. Michael Creech, Senior Resident - Teaching
2010 Dr. Derek Butterwick, Senior Resident - Teaching
2010 Dr. William Weiss, Senior Resident - Teaching
2010 Dr. Sasha Carsen, Senior Resident - Teaching
2010 Dr. Greg Hansen, Senior Resident - Teaching
2010 Dr. Luke Gauthier, Senior Resident - Teaching
2010 Dr. Majed Alosaimi, Fellow - Teaching
2009 Dr. Dana Pecjak, External Elective Rotation - Teaching
2009 Dr. Jessica Trier, External Elective Rotation - Teaching
2009 Dr. Parham Daneshvar, Senior Resident - Teaching
2009 Dr. Krista Goulding, Senior Resident - Teaching
2009 Dr. Othman Ramadan, Senior Resident - Teaching
2009 Dr. Sulaiman Almousa, Senior Resident - Teaching
2008 - 2009 Dr. Michael Lapner, Senior Resident - Teaching
2008 - 2009 Dr. Wazzan Aljuhani, Fellow - Teaching
2008 - 2009 Dr. Maher Khan, Senior Resident - Teaching
2008 - 2009 Dr. Maher Khan, Senior Resident - Teaching
2008 Dr. Michael Lapner, PGY 3 research rotation
Joel Werier
Printed 2015 October 27 10
2008 Dr. Will McCormick, Senior Resident - Teaching
2008 Dr. Maurice Tom-Pack, Senior Resident - Teaching
2007 Dr. Hossein Pakzad, Senior Resident - Teaching
2007 Dr. Megan Cashin, Senior Resident - Teaching
2007 Dr. Sebastian Rodriguez, Senior Resident - Teaching
2006 - 2008 Dr. Hesham Abdelbary, M.Sc. - Research
2006 Dr. Darryl Young, Senior Resident - Teaching
2006 Dr. Steve Mussett, Senior Resident - Teaching
2006 Sr. Amre Hamdi, Senior Resident - Teaching
2006 Dr. P.J. Latanzio, Senior Resident - Teaching
2006 Dr. Hesham Abdelbary, Senior Resident - Teaching
2005 - 2008 Dr. Chris Brown, Ph.D. - Research
2005 - 2006 Dr. Husam Darwish, Senior Resident - Teaching
2005 Dr. Paul Shim, Senior Resident - Teaching
2005 Dr. Wadih Matar, Senior Resident - Teaching
2005 Dr. Hesham Abdelbary, Senior Resident - Teaching
2005 Dr. Paul Shim, Senior Resident - Teaching
2005 Dr. Sahal Al-Tamimi, Senior Resident - Teaching
2004 Dr.Chris Browm, Senior Resident - Teaching
2004 Dr. Chris Brown, Senior Resident - Teaching
2004 Dr. Stephen Kingwell, Senior Resident - Teaching
Peer Review Activities
2014 external reviewer McMaster Orthopaedic Program, McMaster University, external reviewer
McMaster Orthopaedic Program
2010 - present Reviewer for Scientific Journal, reviewer/member, Cancer Care Ontario Program in Evidence
Based Care, Cancer Care Ontario Program in Evidence Based Care
2009 - present Reviewer for Scientific Journal, reviewer Canadian journal of surgery (ad hoc), Canadian
Journal of Surgery, reviewer research articles
Joel Werier
Printed 2015 October 27 11
2008 - present Reviewer for Scientific Journal, reviewer Sarcoma Journal, journal sarcoma, reviewer
research articles
2008 Reviewer - research grant, grant reviewer PSI foundation
2007 external reviewer Toronto Orthopaedic Program, McMaster University, external reviewer
Univerwsity of Toronto Competency Based Orthopaedic Program
PUBLICATIONS
Refereed Journal articles
1. Gregory William Hansen, M.D., BSc; Andrew Smith, M.Sc; J W Pollock, M.D., M.Sc; Joel Werier , M.D.;
Robert Nairn, M.D.; Kawan S Rakhra, M.D.; Dan Benoit, Ph.D; Steven Papp, M.D., M.Sc. Title:
Anatomical repair of the distal biceps tendon cannot be consistently performed through a classic single incision
suture anchor technique
Journal of Shoulder and Elbow Surgery. Journal of Shoulder and Elbow Surgery
Ms. Ref. No.: JSES-D-14-00214R1. Oct 2014.
2. Rebecca E. Thornhill, PhD, Mohammad Golfam, MD, Adnan Sheikh, MD, Greg O. Cron, PhD,
Eric A. White, MD, Joel Werier, MD, Mark E. Schweitzer, MD, Gina Di Primio, MD. Differentiation of
Lipoma From
Liposarcoma on MRI Using Texture
and Shape Analysis. Academic Radiology, Vol 21, No 9, September 2014.
3. M. Ghert md msc,X. Yao msc,† T. Corbett md,‡
A.A. Gupta md msc,§ R.A. Kandel md,||
S. Verma md,# and J. Werier md**: Sarcoma Disease Site Group of Cancer Care Ontario’s Program in
Evidence Based Care. Treatment and follow-up strategies in desmoid tumours: a practice guideline. Current
Oncology—Volume 21, Number 4, August 2014.
4. X. Yao msc,T. Corbett md,† A.A. Gupta md msc,‡
R.A. Kandel md,§ S. Verma md,|| J. Werier md,#
and M. Ghert md msc**: Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence Based
Care. A systematic review of active treatment options in patients with desmoid tumours. Current
Oncology—Volume 21, Number 4, August 2014.
5. Maher R. Baroudi MD1, Peter C. Ferguson MD2, Jay S. Wunder MD2, Marc H. Isler MD3, Sophie Mottard
MD3, Joel A. Werier MD4 andRobert E. Turcotte MD. Forearm soft tissue sarcoma: Tumors characteristics and
oncologic outcomes following limb salvage surgery. Journal of Surgical Oncology
Article first published online: 9 JUN 2014
DOI: 10.1002/jso.23686.
6. Hesham Abdelbary,1 Christopher W. Brown,1,2 Joel Werier,1 and John Bell3. Using Targeted Virotherapy to
Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back. The Scientific World
Journal
Volume 2014 (2014), Article ID 171439, 11 pages
http://dx.doi.org/10.1155/2014/171439.
Joel Werier
Printed 2015 October 27 12
7. Kandel R, Coakley N, Werier J, Engel J, Ghert M, Verma S: Sarcoma Disease Site Group of Cancer Care
Ontario’s Program in Evidence Based Care. Surgical margins and handling of soft-tissue sarcoma in
extremities: a clinical practice guideline. Curr Oncol 2013 Jun;20(3):e247-54 doi: 10.3747/co20.1308.
8. S AlSulaimani, R Turcotte and Canadian Orthopaedic Oncology Society Collaborators: P Ferguson, J Wunder,
M Isler, S. Mottard, M Ghert, B. Deheshi, J Werier, N Dion. Iterative Curettage is associated with local control
in giant cell tumours involving the distal tibia. Clinical Orthopaedics and Related Research
April 2013.
9. Riad S, Biau D. Holt GE, Werier J, Turcotte RE, Ferguson PC, Griffin AM, Dickie CI, Chung PW, CAtton CN,
O’Sullivan B, Wunder JS. The Clinical and Functional Outcome for Patients with Radiation Induced Soft
Tissue Sarcoma. Cancer. 2012 May 15;118(10):2682-92. Epub 2011 Oct 11.
10. Moreau L., Turcotte R., Ferguson P., Wunder J., Clarkson P., Masri B, Isler M., Dion N., Werier J., Ghert M.,
Deheshi B. Myxoid/Round Cell Liposarcoma Revisited: An analysis of 418 Primarily Managed Cases. Ann
Surg Oncol, 2012 Apr; 19(4):1092-8. Epub 2011 Nov4.
11. Gortzak Y, Kandel R, Deheshi B, Werier J, Turcotte RE, Ferguson PC, Wunder JS. The efficacy of chemical
adjuvants on giant cell tumor of bone: an in vitro study. J Bone Joint Surg Br. 2010 Oct;92(10):1475-9.
12. Thi Lien-Anh Nguyên*,†, Hesham Abdelbary†,‡, Meztli Arguello*, Caroline Breitbach‡, Simon Leveille*,§,
Jean-Simon Diallo‡, Amber Yasmeen¶, Tarek A. Bismar¶,‖, David Kirn**, Theresa Falls‡, Valerie E.
Snoulten‡, Barbara C. Vanderhyden‡, Joel Werier‡, Harold Atkins‡, Markus J. V. Vähä-Koskela‡, David F.
Stojdl††, John C. Bell‡,‡‡, and John Hiscott*,§,‡‡. Chemical targeting of the innate antiviral response by
histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proceedings of the National
Academy of Sciences, vol. 105 no. 39,14981-14986. Sep 30, 2008.
13. Dickson BC, Li SQ, Wunder JS, Ferguson PC, Eslami B, Werier JA, Turcotte RE, Kandel RA. Giant Cell
Tumors of Bone Express p63. Mod Pathol. 2008 Apr;21(4):369-75. Epub 2008 Feb 29.
14. B. Dickson, S. Li, J. Wunder, P. Ferguson, B. Eslami, J. Werier, R. Turcotte, R. Kamdel Modern Pathology (
2008) 21, 369-375. Giant Cell Tumor of Bone Expresses p63. Modern Pathology ( 2008) 21, 369-375.
15. Steve H. Thorne, Tae-Ho H. Hwang, William E. O’Gorman, David L. Bartlett, Shizuko Sei, Femina Kanji,
Christopher Brown, Joel Werier, Jin-Han Cho, Dong-Ewon Lee, Yaohe Wang, John Bell, and David H. Kirn.
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus,
JX-963. J. Clin. Invest. 117:3350-3358 (2007).
16. Shaheen, Mahmood MD *; Deheshi, Benjamin M MD,FRCSC; Riad, Soha BSc *; Werier, Joel MD,FRCSC +;
Holt, Ginger E MD ++; Ferguson, Peter C MD, MSc,FRCSC *; Wunder, Jay S MD, MSc,FRCSC. Prognosis of
Radiation-induced Bone Sarcoma is Similar to Primary Osteosarcoma. Clinical Orthopaedics & Related
Research. 450:76-81, September 2006.
17. Werier J., Ferguson P., Bell R., Hill R., Wunder J., O’Sullivan B., Kandel R. A Model of Radiation
Impaired-Healing of a Deep Excisional Wound. .Wound Repair Regen. 2006 Jul-Aug;14(4):498-505.
18. R. Kandel, S.Q.Li, R. Bell. J Wunder, P. Ferguson, A. Kauzman, J.A. Diehl, J. Werier. Cyclin D1 and p 21 Is
Elevated in the Giant Cells of Giant Cell Tumors. J Orthop Res. 2006 Mar;24(3):428-37.
19. Moro J.K., Werier J.M., MacDermid J.C., Patterson S.D., King G.J.W. Arthroplasty with a Metal Radial Head
for Unreconstructible Fractures of the Radial Head. Journal of Bone and Joint Surgery (Am.), August, 2001;
83-(8): 1201-1211.
Joel Werier
Printed 2015 October 27 13
20. Keating, J., Werier, J., Blachut P., Broekhuyse, H., Meek R.N., O’Brien, P.J. Early Fixation of the Vertically
Unstable Pelvis - the role of iliosacral screw fixation of the posterior lesion. Journal of Orthopaedic Trauma,
February, 1999; 13(2):107-113.
21. Janzen DL, Aippersbach SE, Munk PL, Sallomi DF, Garbuz D, Werier J, Duncan CP. Three-dimensional CT
measurement of adult acetabular dysplasia: Technique, preliminary results in normal subjects, and potential
applications. Skeletal Radiology, July, 1998; 27(7):.
22. Werier, J., Keating J., Meek R.N. Complete Dislocation of the Knee - Is Immediate Ligamentous
Reconstruction Worthwhile? The Knee, 1998; 5:255-260.
23. Werier. J., Ducas, J., Prewitt R.M. Effect of low molecular weight heparin on recombinant tissue plasminogen
activator induced thrombolysis in canine pulmonary embolism. Chest, August, 1991; 100:464-469.
Book Chapters and Review Articles
1. Timothy Asmis, Joel Werier, Shailendra Verma. Osteogenic Sarcoma and Dedifferenciated Chondrosarcoma
Surveillance Counterpoint: Canada. Patient Surveillance after Cancer Treatment
Current Clinical Oncology 2013, pp 249-250.
2. Werier, J. Bone Graft Substitutes in Oncology, Paediatrics, and Hip Arthroplasty. Canadian Orthopaedic
Association Bulletin #95 Winter 2011.
3. Werier, J. Failed ORIF and Nonunion of Distal Humeral Fractures. Canadian Orthopaedic Association Bulletin.
Jun 15, 2010.
Invited Editorials
1. Sudheer Bathina, MDa, Adnan Sheikh, MDa, Gina Di Primio, MD, FRCPCa, Joel Werier, MD, FRCPSb,
Kawan Rakhra, MD, FRCPC. Case of the Month - Osteoid Osteoma. Canadian Association of Radiologists
Journal Volume 60, Issue 1, Pages 56-58 (February 2009)
14 of 16.
Published Abstracts
1. L Simmonds, J Werier, L Paquet, S. Verma. Timelines for multidisciplinary limb soft tissue management.
ASCO May 29, 2015 www.asco.org and jco.ascopubs.org starting May 13, 2015.
edit entry when online. published abstract only. In Press.
2. Michelle Ghert, Benjamin Deheshi, Ginger Holt, R Lor Randall, Peter Ferguson, Jay Wunder, Robert Turcotte,
Joel Werier, Timothy Damron, Joseph Benevenia, Megan Anderson, Mark Gebhardt, Marc Isler, John Healey,
Nathan Evaniew, Antonella Racano, Sheila Sprague, Marilyn Swinton, Dianne Bryant, Lahana Thabane, Gordin
Guyatt, Mohit Bhandari, The Parity Investigators. Prophylactic antibiotic regimens in tumour surgery (
PARITY): protocol for a multicentre randomized controlled study. British Medical Journal Open 2012;2
e002197.
3. Werier J.M., Garbuz D.S., Younger A.S.E., Masri B.A., Janzen D.L., Duncan, C.P. The Reliability of the
False Profile View and Center Edge Angle in the Dysplastic Hip. Journal of Bone and Joint Surgery (Br.)
1998;80 (suppl 1):9.
4. Werier, J., Cheung, A., Matas A. Anaphylactic hypersensitivity reaction after repeat OKT3 treatment. Lancet,
1991; 33:1351.
Joel Werier
Printed 2015 October 27 14
Conference Poster
1. M Heng, AM Griffin, A Gupta, AK Callan, GE Holt, S. Mottard, M Isler, R Turcotte, P-U Tunn, M Ghert, J
Werier, P Clarkson, PC Ferguson, JS Wunder. Oncologic Outcomes of the Management of Soft Tissue
Osteosarcoma. Connective Tissue Oncology Society, Berlin, Germany October 16-18, 2014. In Press.
2. Abdelbary, H., Brown C., Werier J., Bell J. Treating Resistant Ewing Sarcoma Using Oncolytic Virus Therapy:
From the bedside to the bech and back. Connective Tissue Oncology Society Annual Meeting - London
England. Nov 13, 2008.
3. Rita A. Kandel1, Shu-Qiu Li1, Joel Werier2, Robert Turcotte3, Peter Ferguson4, Jay Wunder4. Giant Cell
Tumors of Bone Express P63. connective tiisue oncology society meeting, venice, italy, Nov 2-4, 2006. In
Press.
4. Brown C., Wunder J., Ferguson P., Bell R., Bell J., Werier J. Vesicular Stomatis Virus demonstrates ‘in vitro’
oncolytic activity in high grade bone and soft tissue sarcoma. Connective Tissue Oncology Society meeting
Nov. 19-21, 2005.
5. Brown C., Wunder J., Ferguson P., Bell R., Bell J., Werier J. Vesicular Stomatitis Virus demonstrates “in vitro”
Oncolytic Activity in High Grade Bone and Soft Tissue Sarcoma. Musculoskeletal Tumor Society, Nashville,
Tennessee, May 2005.
6. Werier J., Bell R., Hill R., Wunder J., O’Sullivan B., Kandel R. The Effect of Small-Intestinal Submucosa on
Wound Healing in an Irradiated Rat Excisional Wound Model. Canadian Orthopaedic Association, Victoria,
British Columbia, June 2002.
7. Werier J., Bell R., Hill R., Wunder J., O’Sullivan B., Kandel R. The Effect of Small-Intestinal Submucosa on
Wound Healing in an Irradiated Rat Excisional Wound Model. The Wound Healing Society 12th Annual
Symposium, Baltimore, Maryland, May, 2002.
INVITED PRESENTATIONS AND REPORTS
Invited Lectureships
1. J Werier What are Orthopaedic Surgeons doing in 2015 for Bone Metastases. The Ottawa Hospital Cancer
Centre. Ottawa, Ontario, Canada
2. Joel Werier Malignant Soft Tissue Tumours. Canadian Orthopaedic Resident Review in Reconstructive Surgery
(CORR-RECON) course. Toronto, Ontario, Canada Jan 16, 2015.
3. T Marion, A Pipe, S Papp, A Liew, F Momoli, J Werier Smoking Cessation Within the Orthopaedic
Population-Smoking Cessation Intervention Within the Fracture Clinic Primary Investigator. Ottawa, Ontario,
Canada Jan 13, 2015.
4. Werier, J Metastatic Bone Disease: From Bedside to Bench and Back Invited Visiting Professor. Queen’s
University Division of Orthopaedic Surgery. Kingston, Ontario, Canada Dec 10, 2014.
5. Werier, J Resident Tumour Symposium Invited Visiting Professor. Queen’s University Division of Orthopaedic
Surgery. Kingston, Ontario, Canada Dec 10, 2014.
6. Werier J.,Isler M Canadian Orthopaedic Association Basic Science Course - Tumor Symposium - Management
of Soft Tissue Sarcomas - Management of Malignant BoneTumors. Ottawa, Ontario, Canada Oct 31, 2014.
Joel Werier
Printed 2015 October 27 15
7. Werier J Oncolytic Viruses as a Therapeutic Platform Invited Instructional Course. Canadian Orthopaedic
Association. Winnipeg, Manitoba, Canada Jun 21, 2013.
8. Werier J. Resident Tumour Symposium invited lecturer. University of Manitoba. Winnipeg, Manitoba, Canada
Apr 15, 2013.
9. future direction of cancer research - and why your support matter! invited lecture. Valeries flutter Foundation.
Ottawa, Ontario, Canada Oct 12, 2012.
10. Werier, J The Susceptibility of Human and Bone and Soft Tissue Sarcoma to Vaccinia and Maraba Oncolytic
Virus. University of Toronto. Toronto, Ontario, Canada Jan 27, 2012.
11. Joel Werier Malignant Soft Tissue Tumours. Canadian Orthopaedic Resident Review in Reconstructive Surgery
(CORR-RECON) course. Toronto, Ontario, Canada Jan 20, 2012.
12. Werier, J Technique for Managing Massive Bone and Soft Tissue Loss About the Elbow - Instructional Course
Lecture Invited Speaker. Canadian Orthopaedic Association. St. John’s, Canada Jul 9, 2011.
13. Werier, J Dealing with the Problem Resident -Symposia Invited Speaker. Canadian Orthopaedic Association.
St. John’s, Canada Jul 8, 2011.
14. J. Werier Update on Management of Metastatic Bone Disease. Ontario Orthopaedic Association. Toronto,
Ontario, Canada Nov 5, 2010.
15. Werier J, Isler M Integrating Practical Musculoskeletal Oncology into an Orthopaedic Curriculum -
Instructional Course Lecture Invited Lecture Instructional Course. Canadian Orthopaedic Association.
Edmonton, Alberta, Canada Jun 19, 2010.
16. Werier J Knee Reconstruction in the Very Young Presenter Invited Lecture. McGill University Sarcoma Day.
Montreal, Quebec, Canada May 6, 2010.
17. Werier J Modular Oncology Prothesis for massive bone loss – the salvage situation Invited Lecture. The Second
Affiliated Hospital, Wenzhou, China. Wenzhou, China Oct 10, 2009.
18. Werier J Pediatric growing joint prosthesis - current state of the art Invited Lecture. The Second Affiliated
Hospital, Wenzhou, China. Wenzhou, China Oct 9, 2009.
19. Ulnar Wrist Pain, Diagnosis and Treatment. University of Ottawa Upper Extremity Course. Ottawa, Ontario,
Canada May 9, 2009.
20. Indications and description of distal biceps repair. University of Ottawa Upper Extremity Course. Ottawa,
Ontario, Canada May 9, 2009.
21. Werier, Brown, Bell Treating Sarcomas Using Viral Oncolytic Therapy - From Bedside to Bench and Back.
Rosen-Daniels Visiting Professorship in Surgical Oncology Translational Research. Toronto, Ontario, Canada
Oct 31, 2008.
22. Wrist Anatomy. Ottawa Resident Wrist Course. Ottawa, Ontario, Canada May 17, 2008.
23. Arthrofibrosis. Ottawa Resident Wrist Course. Ottawa, Ontario, Canada May 17, 2008.
24. Surgical Principles in the Management of Sarcoma. Combined Oncology Course - Sarcoma section. Ottawa,
Ontario, Canada Apr 23, 2008.
Joel Werier
Printed 2015 October 27 16
25. Advances in Pediatric Limb Salvage. Perioperative Registered Nurses Association. Ottawa, Ontario, Canada
Oct 13, 2007.
26. Anatomy and Physiology of the Musculoskeletal System. H. Kellam Annual Orthopaedic Nursing Seminar.
Ottawa, Ontario, Canada Oct 2, 2007.
27. update on total elbow athroplasty. canadian orthopaedic nurses association. ottawa Mar 31, 2007.
28. Werier J. Canadian Orthopaedic Association Basic Science Course - Tumor Symposium - Management of Soft
Tissue Sarcomas - Management of Benign Bone Tumors. Oct 27, 2005.
29. Werier, J. Instructional Course Lecture - Recent Advances in Bone Sarcomas - Management. Canadian
Orthopaedic Association Annual Meeting. Jun 3, 2005.
30. Werier J. Canadian Orthopaedic Association Basic Science Course - Tumor Symposium - Management of Soft
Tissue Sarcomas - Management of Benign Bone Tumors. Oct 29, 2004.
31. J. Werier. Bone and Soft Tisse Tumours. Division of Orthopaedic Surgery, Queens University. Kingston,
Ontarion Mar 31, 2004.
National and International Meeting Presentations
1. Turcotte R, Sawan H, Ferguson P, Wunder J, Isler M, Mottard C, Abdelbary H, Werier J Giant Cell Tumour of
the Distal Radius collborator. Canadian Orthopaedic Asssociation. Vancouver, British Columbia, Canada Jun
19, 2015.
2. Vu H. Le1, Carolyn Faught2, Joel Werier3 HAIRY CELL LEUKEMIA MASQUERADING AS
AVASCULAR NECROSIS OF THE HIP PI. Connective Tissue Oncology Society. Berlin, Unknown, Germany
Oct 17, 2014.
3. Tice, A, Hynes K, Verma S, Werier, J HAIRY CELL LEUKEMIA MASQUERADING AS AVASCULAR
NECROSIS OF THE HIP PI. Connective Tissue Oncology Society. Berlin, Unknown, Germany Oct 17, 2014.
4. Michelle Ghert, Xiaomei Yao, Tom Corbett, Abha Gupta, Rita Kandel, Joel Werier, Shailendra Verma, and the
Sarcoma Disease Site Group of Cancer A GUIDELINE BY THE PROGRAM FOR EVIDENCE-BASED
CARE OF CANCER CARE ONTARIO: DESMOID TUMORS Co-PI. Connective Tissue Oncology Society.
Berlin, Unknown, Germany Oct 17, 2014.
5. Baroudi M, Ferguson P, Wunder J, Isler M, Mottard S, Werier J, Turcotte R Outcomes Following Initial
Management of Non Metastatic Soft Tissue Sarcoma of the Forearm; a multi institutional study collborator.
American Orthopaedic Association/Canadian Orthopaedic Asssociation. Montreal, Quebec, Canada Jun 20,
2014.
6. Baroudi M, Ferguson P, Wunder J, Isler M, Mottard S, Werier J, Turcotte R Outcomes Following Initial
Management of Non Metastatic Soft Tissue Sarcoma of the Forearm; a multi institutional study collborator.
Musculoskeletal Tumour Society. San Francisco, California, United States Oct 4, 2013.
7. Goulding KA; Pahuta M, Chang Y; D’Sa H; Sampaio M; Kolanko N; Sheikh A; DiPrimio G; Schweitzer M;
Werier JW Should Magnetic Resonance Imaging for Tumours of the Musculoskeletal system be performed in a
Sarcoma-designated Health Care Centre? Primary Investigator. British Orthopaedic Association Congress 2013.
Birmingham, Birmingham, United Kingdom Oct 4, 2013.
8. Meulenkamp B, Werier J The Use of an Incisional Vac in Sarcoma Sarcoma Surgery - Outcomes of Wounds at
Risk Primary Investigator. Canadian Orthopaedic Association. Winnipeg, Manitoba, Canada Jun 21, 2013.
Joel Werier
Printed 2015 October 27 17
9. Goulding KA; Pahuta M, Chang Y; D’Sa H; Sampaio M; Kolanko N; Sheikh A; DiPrimio G; Schweitzer M;
Werier JW Should Magnetic Resonance Imaging _for Tumours of the Musculoskeletal system be performed in
a _Sarcoma-designated Health Care Centre? Primary Investigator. Canadian Orthopaedic Association.
Winnipeg, Manitoba, Canada Jun 21, 2013.
10. Werier J, Rancourt M., Gofton W Then Ottawa Orthopaedic Orientation Primary Investigator. Canadian
Orthopaedic Association. Winnipeg, Manitoba, Canada Jun 20, 2013.
11. Thornhill R, Cron G, Golfam M, DiPrimio G, Sheikh A, White E, Werier J, Schweitzer M Can 3D Shape and
textural analysis differenciate liposarcomas from benign lipomas? collaborator. The International Society for
Magnetic Resonance in Medicine. Salt Lake CIty, Utah, United States Apr 24, 2013.
12. Goulding KA; Pahuta M, Chang Y; D’Sa H; Sampaio M; Kolanko N; Sheikh A; DiPrimio G; Schweitzer M;
Werier JW Should Magnetic Resonance Imaging _for Tumours of the Musculoskeletal system be performed in
a _Sarcoma-designated Health Care Centre? Primary Investigator. British Orthopaedic Oncology Society.
Manchester, Manchester, United Kingdom Apr 19, 2013.
13. Greg Hansen, J Pollock, Joel Werier, Kawan Rakhra, Steve Papp Anatomical Repair of the Distal Biceps
Tendon May not be possible through a single anterior incision. Canadian Orthopaedic Association. Ottawa,
Ontario, Canada Jun 10, 2012.
14. Joel Werier, Hesham Abdelbary, Jovian Tsang, Derek Butterwick, Jay Wunder, Jean-Simon Diallo, John Bell
The Susceptibility of Human and Bone and Soft Tissue Sarcoma to Vaccinia and Maraba Oncolytic Virus
Co-PI. Canadian Orthopaedic Association. Ottawa, Ontario, Canada Jun 9, 2012.
15. Saleh Alsulaimani, Peter Ferguson, Jay Wunder, Mark Isler, Sophie Motard, Joel Werier, Benjamin Deheshi,
Norbert Dion, Michelle Ghert, Robert Turcotte Giant Cell Tumour Arising in the Tibia collaborator. Canadian
Orthopaedic Association. Ottawa, Ontario, Canada Jun 9, 2012.
16. Brenda Ashe, Joel Werier Functional Stages of Recovery Following Sarcoma Resection Primary Investigator.
Canadian Orthopaedic Nurses Assocaition. Ottawa, Ontario, Canada Jun 5, 2012.
17. Derek Butterwick, Jovian Tsang, Hesham Abdelbary, Jay Wunder, John Bell, Joel Werier Vaccinia JX-594 an
an Oncolytic Agent in Bone and Soft Tissue Sarcomas Co-PI. Connective Tissue Oncology Society. Chicago,
Illinois, United States Oct 26, 2011.
18. Louis Moreau, Robert Turcotte, Peter Ferguson, Jay Wunder, Paul Clarkson, Bas Masri, Mark Isler, Norbert
Dion, Joel Werier, Benjamin Deheshi Myxoid and Round Cell Liposarcoma of the Extremity and the Trunk
Reviseted: A Review of 418 Cases collaborator. Connective Tissue Oncology Society. Chicago, Illinois, United
States Oct 26, 2011.
19. Canadian Orthopaedic Oncology Society Myxoid-round Cells Liposarcoma Revisited: A Canadian Experience
collaborator. Canadian Orthopaedic Association. St. John’s, Canada Jul 9, 2011.
20. B. Ashe, J. Werier Functional Stages of Recovery following Sarcoma Resrection. Canadian Association of
Occupational Therapists. Saskatoon, Saskatchewan, Canada Jun 15, 2011.
21. R. Thornhill, G. Cron, I Cameron, A Sheikh, G DiPRimio, J Werier, M Schweitzer, J Xhang, X Cheng
Combined MRI texture and shape analysis for the prediction of biologic aggressiveness in musculoskeletal
neoplasms. International Society of Magnetic Resonance Imaging in Medicine. Quebec City, Quebec, Canada
May 7, 2011.
Joel Werier
Printed 2015 October 27 18
22. S. Riad; A. Griffin; G. Holt; J. Werier; R. Turcotte; P. Ferguson; C. Catton; P. Chung; B. O’Sullivan; J. Wunder
Clinical and Functional Outcomes for patients with Radiation Induced Soft Tissue Sarcoma. Connective Tissue
Oncology Society. Paris, France Nov 11, 2010.
23. S. Riad; A. Griffin; G. Holt; J.; R. Turcotte; J. Werier; P. Ferguson; C. Catton; P. Chung; B. O’Sullivan; J.
Wunder Clinical and Functional Outcomes for patients with Radiation Induced Soft Tissue Sarcoma.
Musculoskeletal Tumor Society. Philadelphia, Pennsylvania, United States Oct 1, 2010.
24. Lapner M, Werier J Open Reduction and Internal fixation versus and Expandable Intramedullary Nail for the
Treatment of Pathologic Humerus Fractures Supervising/Primary Author. Canadian Orthopaedic Association.
Edmonton, Alberta, Canada Jun 19, 2010.
25. Deheshi B, Safir A, Griffin A, Werier J, Turcotte R, Ferguson P, Wunder J Prognostic Value of Postoperative
Infection in Bone Sarcoma co-author/collaborator. International Society of Limb Salvage
Surgery/Musculoskeletal Tumour Society. Boston, Massachusetts, United States Sep 26, 2009.
26. Brown C., Werier J., Bell J. A Novel Targeted Oncolytic Virus Approach for Diffuse Metastatic Disease.
Canadian Orthopaedic Association Meeting. Quebec City, Quebec, Canada Jun 4, 2008.
27. Werier J. Abdelbary H., Brown C., Bell, J. Oncolytic Viral Therapy: A Novel Biotherapuetic Approcah in
Treating Ewing’s Sarcoma. Canadian Orthopaedic Association Meeting. Quebec City, Quebec, Canada Jun 4,
2008.
28. Abdelbary H. Bell, J., Werier J. Histone Deacetylase Inhibitors and Vesicular Stomatits Virus: A Combination
Tumor Targeting Therapy. Canadian Orthopaedic Association Meeting. Quebec City, Quebec, Canada Jun 4,
2008.
29. Abdelbary H., Brown C., Werier J., Wunder J., Bell, J. Oncolytic Viral Therapy: A Novel Biotherapuetic
Approcah in Treating Sarcomas. Connective Tissue Oncology Society. Seattle, Washington Nov 1, 2007.
30. Abdelbary H. Bell, J., Werier J. Histone Deacetylase Inhibitors and Vesicular Stomatits Virus: A Combination
Tumor Targeting Therapy. Connective Tissue Oncology Society. Seattle, Washington Nov 1, 2007.
31. Brown C., Werier J., Bell J. A Novel Targeted Oncolytic Virus Approach for Diffuse Metastatic Disease.
Connective Tissue Oncology Society. Seattle, Washington Nov 1, 2007.
32. Shaheen M., Riad S., Griffin A., McLaughlin C., Werier J., Holt G., Schwartz H., Ferguson P., Bell R., Wunder
J. The Functional and Oncologic Outcome of Post-Irradiation Sarcoma of Bone. Musculoskeletal Tumor
Society, Nashville, Tennessee, May 2005.
33. C. McLaughlin, J. Werier, G. Holt, R. Wupperman, H. Schwartz, P. Ferguson, R. Bell, J. Wunder. The
Functional and Oncologic Outcome of Post Radiation Sarcoma of Bone. Muscoloskeletal Tumor Society.
Nashville, Tennessee May 20, 2005.
34. Werier J., Bell R., Hill R., Wunder J., O’Sullivan B., Kandel R. The Effect of Small-Intestinal Submucosa on
Wound Healing in an Irradiated Rat Excisional Wound Model. Canadian Society of Surgical Oncology,
Montreal, Quebec, April 2002.
35. Werier J., Bell R., Hill R., Wunder J., O’Sullivan B., Kandel R. The Effect of Small-Intestinal Submucosa on
Wound Healing in an Irradiated Rat Excisional Wound Model. Musculoskeletal Tumor Society, Toronto,
Ontario, April, 2002.
Joel Werier
Printed 2015 October 27 19
Regional and Local Meeting Presentations
1. Dowding C, Addison C, , Werier J Synergism Amongst A Focal Adhesion Kinase Inhibitor (PF-562,271) and
Cadidate Chemotherapeutic Drugs for the Treatment of Bone Metastatses Co-Primary Investigator. Collin’s
Day Dept of Surgery Research Day (poster). Ottawa, Ontario, Canada May 9, 2014.
2. D’Sa H, Goulding KA; Pahuta M, Chang Y; ; Sampaio M; Kolanko N; Sheikh A; DiPrimio G; Schweitzer M;
Werier JW Should Magnetic Resonance Imaging for Tumours of the Musculoskeletal system be performed in a
Sarcoma-designated Health Care Centre? Primary Investigator. HK Uhthoff Orthopaedic Research Day.
Ottawa, Ontario, Canada Apr 24, 2014.
3. Marion T, Pipe A, Momoli F, Papp S, Liew A, Werier J Smoking Cessation Intervention Within The Fracture
Clinic: A Prospective Double Cohort Primary Investigator. HK Uhthoff Orthopaedic Research Day. Ottawa,
Ontario, Canada Apr 24, 2014.
4. MacNiven, I, Werier J, Feibel R, Gofton W, Beaule P Clinical and Radiographic Analysis of the Gap
Restoration Acetabular Cup in Total Hip Arthroplasty Collaborator. HK Uhthoff Orthopaedic Research Day.
Ottawa, Ontario, Canada Apr 24, 2014.
5. Dowding C, Addison C, Clemons M, Werier J Synergism Amongst A Focal Adhesion Kinase Inhibitor
(PF-562,271) and Cadidate Chemotherapeutic Drugs for the Treatment of Bone Metastatses Co-Primary
Investigator. HK Uhthoff Orthopaedic Research Day. Ottawa, Ontario, Canada Apr 24, 2014.
6. Gregory Hansen1, Andrew Smith2, M.Sc., MD, FRCSC J Whitcomb Pollock1, MD, MSc, FRCSC, Joel Werier
1, MD,
FRCSC Dr. Robert Nairn3, MD, FRCPC, Kawan S. Rakhra3, MD, FRCPC, Dan Benoit PhD2, Steven Papp,
MD, MSc
FRCSC1 Anatomical repair of the distal biceps tendon cannot be consistently performed through a classic
single incision suture anchor technique. Ottawa, Ontario, Canada Nov 14, 2013.
7. Youjin Chang1, KA Goulding1, H D’Sa1, M Pahuta2, A Sheikh2, G DiPrimio2, N Kolenko2, M Sampaio2, M
Schweitzer2,
JW Werier1 Should magnetic resonance imaging for tumours of the musculoskeletal system be performed in
a sarcoma-designated health care centre? Ottawa, Ontario, Canada Nov 14, 2013.
8. Rancourt MF, Gofton W, Werier J Then Ottawa Orthopaedic Orientation (poster Primary Investigator. The
Ottawa Hospital. Ottawa, Ontario, Canada Oct 29, 2013.
9. Meulenkamp B, Werier J The Use of an Incisional Vac in Sarcoma Sarcoma Surgery - Outcomes of Wounds at
Risk Primary Investigator. Department of Surgery, University of Ottawa. Ottawa, Ontario, Canada May 10,
2013.
10. Goulding KA; Pahuta M, Chang Y; D’Sa H; Sampaio M; Kolanko N; Sheikh A; DiPrimio G; Schweitzer M;
Werier JW Should Magnetic Resonance Imaging _for Tumours of the Musculoskeletal system be performed in
a _Sarcoma-designated Health Care Centre? Primary Investigator. Canadian Orthopaedic Association. Ottawa,
Ontario, Canada May 10, 2013.
11. G Bayley, M Pahuta, C van Walraven, D Coyle, J Werier, E Wai A Systematic Review of the Quality of
Evidence for the Treatment of Metastatic Spinal Cord Compression Primary Investigator. Division of
Orthopaedic Surgery, University of Ottawa. Ottawa, Ontario, Canada May 2, 2013.
12. M Pahuta, C Sun, G Mitera, C van Walraven, D Coyle, E. Wai, J Werier Development and Validation of the
Self-Administered Online Assessment of Preferences (SOAP) Tool Primary Investigator. Division of
Orthopaedic Surgery, University of Ottawa. Ottawa, Ontario, Canada May 2, 2013.
Joel Werier
Printed 2015 October 27 20
13. M Pahuta, C van Walraven, D Coyle, E. Wai, J Werier Societal Valuation of Metastatic Spinal Cord
Compression Health States Primary Investigator. Division of Orthopaedic Surgery, University of Ottawa.
Ottawa, Ontario, Canada May 2, 2013.
14. M Pahuta, R Patchell, E Maranzano, C van Walraven, D Coyle, J Werier, E Wai An individual patient data
meta-regression of the short term treatment of effects for metastatic spinal cord compression Primary
Investigator. Division of Orthopaedic Surgery, University of Ottawa. Ottawa, Ontario, Canada May 2, 2013.
15. Meulenkamp B, Werier J The Use of an Incisional Vac in Sarcoma Sarcoma Surgery - Outcomes of Wounds at
Risk Primary Investigator. Division of Orthopaedic Surgery, University of Ottawa. Ottawa, Ontario, Canada
May 2, 2013.
16. Rancourt MF, Werier, J., Gofton W Then Ottawa Orthopaedic Orientation Primary Investigator. Division of
Orthopaedic Surgery, University of Ottawa. Ottawa, Ontario, Canada May 2, 2013.
17. D. Butterwick, H. Abdelbary, J. Tsang, J. Bell, J. Werier Vaccinia JX-594 as an Oncologic Agent in Bone and
Soft Tissue Sarcomas. Collins Day Department of Surgery. Ottawa, Ontario, Canada May 13, 2011.
18. G. Hansen, J. Pollock, J. Werier, S. Papp Biceps Tendon Footprint in Single Incision Repair. Collin’s Day
Department of Surgery. Ottawa, Ontario, Canada May 13, 2011.
19. D. Butterwick, H. Abdelbary, J. Tsang, J. Bell, J. Werier Vaccinia JX-594 as an Oncologic Agent in Bone and
Soft Tissue Sarcomas. Uhthoff Day Division of Orthopaedic Surgery. Ottawa, Ontario, Canada Apr 28, 2011.
20. G. Hansen, J. Pollock, J. Werier, S. Papp Biceps Tendon Footprint in Single Incision Repair. Uhthoff Day
Division of Orthopaedic Surgery. Ottawa, Ontario, Canada Apr 28, 2011.
21. Lapner, M., Werier J. Open Reduction and Internal Fixation versus an Expandable Intramedullary Nail for the
Treatment of Pathological Humerus Fractures. Collin’s Surgical Day. Ottawa, Ontario, Canada May 8, 2009.
22. Lapner, M., Werier J. Open Reduction and Internal Fixation versus an Expandable Intramedullary Nail for the
Treatment of Pathological Humerus Fractures. H.K Uhtoff Reseach Day. Ottawa, Ontario, Canada Apr 23,
2009.
23. C. Brown, H. Abdelbary, G. Maire, J. Squire, J. Bell, Werier J. Virotherapy of a Treatment Resistant Ewing
Sarcoma – Fom the Bedsise to the Bench and Back. H.K. Uhtoff Day. Ottawa, Ontario, Canada Apr 17, 2009.
24. Oncolytic Virus Therapy: A Novel Approach for treating Cancer
H. Abdelbary, C. Brown, J. Werier, J. Bell Oncolytic Virus Therapy: A Novel Approach for treating Cancer.
Collin’s Surgical Day. Ottawa, Ontario, Canada May 9, 2008.
25. Brown C, Werier J, Bell J. Switching Rhabdovirus G Proteins - A Strategy for Immune Evasion and Tissue
Tropism. Collin’s Day May 11, 2007.
26. Abdelberry H, Bell J, Werier J. Inverstigation the Synergestic Effect of Histone Deacetylase Inhibitors on
Vesicular Stomatis Virus Oncolytic Properties. H.K. Uthoff research Day. Ottawa Apr 19, 2007.
27. Brown C, Werier J, Bell J. Switching Rhabdovirus G Proteins - A Strategy for Immune Evasion and Tissue
Tropism. H.K. Uthoff research Day Apr 19, 2007.
28. H. Abdelbary, J. Bell, J. Werier. In vitro investigation of of the effects of vesicular stomatis virus on human
sarcoma cell lines in the presence of interferon inhibitors. Dept. of Surgery - University of Ottawa Collin’s Day.
Ottawa Jun 12, 2006.
Joel Werier
Printed 2015 October 27 21
29. C. Brown, J. Werier, J. Bell. The Rhabdovirus G Protein demonstrates a specific role in establishing tumor
tropism. Sept.pf Surgery, University of Ottawa. Ottawa May 12, 2006.
30. Brown C., Bell J., Werier J. Vesicular Stomatis Virus demonstrates ‘in vitro’ oncolytic activity in high grade
bone and soft tissue sarcoma. May 13, 2005.
31. Shim P., Wunder J., Bell R., Werier J. Functional and Oncologic Outcome of Chondroblastoma. Apr 21, 2005.
32. Brown C., Bell J., Werier J. Vesicular Stomatis Virus demonstrates ‘in vitro’ oncolytic activity in high grade
bone and soft tissue sarcoma. Apr 21, 2005.
Invited Speaker for Inauguration of New Cancer Foundation
1. Joel Werier New Horizons in Sarcoma Care and Treatment Inaugural Guest Speaker. Valerie’s Flutter
Foundation. Ottawa, Ontario, Canada Oct 22, 2011.
invited speaker sarcoma benefit concert
1. Invited Guest Speaker sarcoma benefit concert. Mackay United Church. Ottawa, Ontario, Canada May 4, 2012.
SERVICE AND ADMINISTRATION
Professional Associations
2008 - present Canadian Orthopaedic Oncology Society, secretary
2008 - present American Academy of Orthopaedic Surgeons
2006 - 2012 Children’s Oncology Group
2003 - present Connective Tissue Oncology Society
2003 - present National Capital Orthopaedic Association, president
1998 - present Canadian Orthopaedic Association
Canadian Orthopaedic Association
Ontario Medical Association
Ontario Orthopaedic Association
National Capital Orthopadic Association, Treasurer
Connective Tissue Oncology Society
Joel Werier
Printed 2015 October 27 22
Professional Activities
2015 Nanobiotix, A multicentre randomized open label phase II/III study, to compare the efficacy
of NBTXR3, implanted as an intra tumour injection and activated by radiotherapy, versus
radiotherapy alone in patient with locally advanced soft tissue sarcoma of the exrtemity and
trunk wall.
Investigators meeting Barcelona April 24, 2015
2012 - present University of Ottawa, development of new research collaborative program looking at bone
metastatis at basic science level. New tumour banking initiative.
2012 Amgen, Giant Cell Tumour of Bone National Advisory Board Meeting
Industry sonsored - Amgen
2011 - present Valerie’s Flutter Foundation, Worked closely with the Goneau family to help found
Valerie’s Flutter Foundation, a recognized charitable organizations to fund and promote
research on the field of sarcoma and musculoskeletal oncology. The foundation is in honour
of Valerie Goneau, whose creative vision was to leave a legacy prior to succumbing to pelvic
osteosarcoma at the age of 19. October 2011 marked the inaugural fundraising event.
2011 Ride the Rideau, Ride the Ride Rideau Sept 10, 2011.
The Orthopaedic Oncology Team raised over $ 40,000 for the Ottawa Hospital Cancer
Program, and was recognized as a top 10 corporate/team sponsor for the event
Administrative Committees
2014 - present Provincial Health Administration Committee, Member, Sarcoma Disease Pathway
Management Owrking Group, Cancer Care Ontario
2013 - present Provincial Health Administration Committee, Member, Provincial Sarcoma Data Working
Group, Cancer Care Ontario
2010 - present Prestigious Society Executive, Secretary, Secretary, Canadian Orthopaedic Oncology Society
( CanOOS)
2009 - present National Health Administration Committee, Member, Cancer Care Ontario expert panel on
provincial sarcoma resources and services
2008 - present Program Head or Director, Chair, Program Director Division of Orthopaedic Surgery
Residency Program, Program Director Division of Orthopaedic Surgery Residency Program
2007 - present Hospital Program Head or Administrative Director, Chair, Chair - Sarcoma Disease Site
Group - Ottawa Hospital Cancer Program
2007 - present National Health Administration Committee, Member, Cancer Care Ontario Program in
Evidence Based Care Sarcoma Disease Site Group - clinical guidlines group
2006 - 2008 National Health Administration Committee, Member, Ontario Tumor Bank Operational
Committee, Ontario Institiute for Cancer Research
2004 - 2011 Hospital Committee Service, Chair, Co-PI Tumor Banking Program Ottawa Hospital
Joel Werier
Printed 2015 October 27 23
2004 - 2008 Hospital Committee Service, Member, operating room committee Ottawa Hospital General
Campus
2004 - 2006 Provincial Health Administration Committee, Member, Tumor Bank Provincial Directorate -
Ontario Cancer Research Network
2003 - present University Committee Service, Member, postgraduate education committee - orthopaedic
surgery
2003 - 2007 Research Grants Committee, Member, clinical research evaluation committee - Ottawa
Hospital regional cancer program
Other Appointments and Activities
2011 - present I am currently a Royal College Examiner and am charged with development of the
musculoskeletal oncology section for the Royal College examination.
2011 - 2014 Vice Chair for the Subspecialty Committee in Orthopaedic Surgery and am a nucleus member
charged with review and recommendation on program accreditation in Orthopaedic Surgery.
2008 - present Since 2008 I have been he program director for the Orthopaedic Surgery Residency Program
at the University of Ottawa. Along with a committed faculty and resident body we received
a very strong and successful accreditation review in 2010 and are well positioned for
successful accreditation in 2016. We have become a program of choice for orthopaedic
training and are viewed favorably among CARMS candidates. In these challenging times
for job opportunities we continue fill our CARMS positions with top tier candidates and I am
proud to say that our graduates continue to be recruited at a high rate to both academic and
community positions. The condensed orthopaedic boot camp (Ottawa Orthopaedic
Orientation) has been a model for early resident integration, accelerated competencies, and
patient safety and has been adopted as a model at several other Canadian Universities.
2004 - present Sarcoma Tumor Banking Program and Prospective Functional and Oncologic Database
Collection at the Ottawa Hospital
2004 - 2011 Ontario Cancer Research Network ProvincialTumor Bank initiative at The Ottawa Hospital
2004 weekly multidisciplinary sarcoma case and pathology review
2004 Comprehensive Multidisciplinary Musculoskeletal Oncology Program (Adult and Pediatric)
for Eastern Ontario
2002 - present Since 2002 I have developed a strong multidisciplinary sarcoma program at The Ottawa
Hospital. I have been involved extensively with Cancer Care Ontario with the consolidation
of Sarcoma Services across Ontario and the submission of the Ottawa Hospital Sarcoma
Services Plan. Cancer Care Ontario has designated The Ottawa Hospital as one of three
sarcoma centers of excellence in Ontario. We will continue to drive this program forward as
a center of excellence and strive to further develop quality-reporting metrics. I am an active
member of Cancer Care Ontario’s Sarcoma Service Steering Committee as well as the
Sarcoma Data Management Working Group and the Sarcoma Disease Pathway Management
Group, which reports to the Sarcoma Steering committee. I as well am an active member to
the Cancer Care Ontario’s Program in Evidence Based Care for sarcoma guideline
development.
Joel Werier
Printed 2015 October 27 24
CONTINUING PROFESSIONAL DEVELOPMENT
2013 Jun 19 - 2013 Jun 22 Canadian Orthpaedic Association
2013 Apr 30 Competency Based training Workshop 2013 Toronto
2013 Apr 11 - 2013 Apr 12 Bonus 8 Meeting ( bone metastasis ) Ottawa
2012 Nov 14 - 2012 Nov 17 Connective Tissue Oncology Society - Prague, Chech Republic
2012 Oct 26 - 2012 Oct 27 Zimmer Skills Training Oncology Segmental System - Warsaw Indiana
2012 Oct 17 - 2012 Oct 18 International Conference on Surgical Education and Training (ICOSET) Ottawa
2012 Sep 28 - 2012 Nov 17 PARITY Launch Meeting Toronto
2010 Jun 25 2010 Biologics Science Summit
2010 Jun 17 - 2010 Jun 20 Canadian Orthoapedic Association Annual; Meeting - Edmonton, Alberta
2010 May 6 McGill University Sarcoma Day
2010 Apr 22 H.K. Uhthoff Orthopaedic Surgery Research day
2010 Apr 16 KCI Vaccum dressing working group
2010 Jan 27 - 2010 Jan 30 International Group of Leading Orthopaedic Oncology Surgeons ( IGLOOS) -
working group - Morzine, France
2009 Nov 13 - 2009 Nov 15 National Capital Orthopaedic Association Annual Meeting
2009 Nov 5 - 2009 Nov 7 Connective Tissue Oncology Society
2009 Sep 23 - 2009 Sep 26 International Society of Limb Salvage Surgery/Musculoskeletal Tumour Society
Combined Meeting
2009 Jul 3 - 2009 Jul 6 Canadian Orthoapedic Association Annual; Meeting - Whistler, BC
2005 Nov 19 - 2005 Nov 21 Connective Tissue Oncology Society - Boca Raton, Florida
2005 Oct 20 - 2005 Oct 22 Orthopaedic Trauma Association - Ottawa, Ont.
2005 Jun 3 - 2005 Jun 5 Canadian Orthopaedic Association - Montreal
2005 May 29 The 2nd International Symposium on Bone and Soft Tissue Tumor - Beijing, China
2005 May 19 - 2005 May 21 Musculoskeletal Tumor Society - Nashville, TN
2005 May 10 - 2005 May 13 International Symposium on Oncolytic Virus Therapy - Banff, Alberta
2005 Feb 10 - 2005 Feb 12 Contemporary Issues in Hip and Knee Surgery - Whistler, Bristish Columbia
Joel Werier
Printed 2015 October 27 25
2004 Nov 20 Mayo Clinic Latitude Elbow Course
2004 Nov 11 - 2004 Nov 13 Connective Tissue Oncology Society - Montreal